-
Press Room
-
Press Releases
-
Nov 07, 2018
9:15 PM
VolitionRx Limited Announces Third Quarter 2018 Financial Results and Business Update
-
Oct 31, 2018
9:15 PM
VolitionRx Limited Schedules Third Quarter 2018 Earnings Conference Call and Business Update
-
Oct 04, 2018
2:15 PM
VolitionRx Limited to Expand its Nu.Q(TM) Trials to Veterinary Diagnostics
-
Sep 26, 2018
2:15 PM
VolitionRx Limited Releases Video Featuring Interviews with its Scientific Advisory Board
-
Aug 13, 2018
9:15 PM
VolitionRx Limited Announces Second Quarter 2018 Financial Results and Business Update
-
Aug 13, 2018
2:15 PM
Preliminary Data from Study Demonstrates 94% Accuracy in Detecting Aggressive Prostate Cancer
-
Aug 09, 2018
2:15 PM
VolitionRx Limited Announces Completion of Sample Collection in Endometriosis Study
-
Aug 08, 2018
11:15 AM
VolitionRx Announces $9 Million Private Placement
-
Aug 07, 2018
2:15 PM
VolitionRx Limited Schedules Second Quarter 2018 Earnings Conference Call and Business Update
-
Aug 01, 2018
12:15 PM
VolitionRx's First Research Use Only Product Is "On-The-Shelf" Today
-
Jul 10, 2018
2:15 PM
Volition Extends Global Reach of its Clinical Trial Program
-
Jul 02, 2018
2:15 PM
Volition Secures Additional $700,000 Non-Dilutive Funding from the Walloon Region
-
May 14, 2018
2:15 PM
VolitionRx Limited to Attend the Bank of America Merrill Lynch 2018 Health Care Conference from May 15-17, 2018
-
May 10, 2018
9:15 PM
VolitionRx Limited Announces First Quarter 2018 Financial Results and Business Update
-
May 09, 2018
4:13 PM
VolitionRx Signs a Global Sales and Distribution Agreement with Active Motif for its new RUO kits
-
May 08, 2018
5:09 PM
VolitionRx Limited Schedules First Quarter 2018 Earnings Conference Call and Business Update
-
Mar 13, 2018
9:00 PM
VolitionRx Announces Closing of $8.4 Million Public Offering of Common Stock
-
Mar 09, 2018
3:00 PM
VolitionRx Announces Pricing of $8.4 Million Public Offering of Common Stock
-
Mar 08, 2018
10:00 PM
VolitionRx Announces Proposed Underwritten Public Offering of Common Stock
-
Mar 07, 2018
2:00 PM
VolitionRx Appoints Harvard Professor, Dr. Lee-Jen Wei to Its Scientific Advisory Board
-
Mar 01, 2018
10:00 PM
VolitionRX Limited Announces Full Fiscal Year 2017 Financial Results and Business Update
-
Feb 28, 2018
10:00 PM
VolitionRx Limited Schedules Full Year 2017 Earnings Conference Call and Business Update
-
Feb 26, 2018
10:00 PM
VolitionRx Limited Announces Interim Results from 680-Subject Clinical Trial in Colorectal Cancer
-
Feb 05, 2018
2:00 PM
VolitionRX Announces the Successful Conclusion of the Logistics and Pathway Design Study Conducted in Denmark.
-
Jan 03, 2018
2:00 PM
VolitionRx Limited Releases Letter to Shareholders Including Status Update on Key Clinical Milestone